Javascript Menu by Deluxe-Menu.com
Minimally Invasive Direct Coronary Artery Bypass Graft Surgery (MIDCAB)

The Indiana Heart Institute (IHI) was the first medical center in Indiana, and one of the first worldwide, to offer MIDCAB.


Mid-CABG Surgery being performed at St.Vincent Hospital

MID CABG
CorVasc MD's was the first cardiovascular surgical team in Indiana, and one of the first worldwide, to offer Minimally Invasive Direct Coronary Artery Bypass Graft Surgery. Drs. Robert Robison, David Heimansohn, Edward Fitzgerald and Keith B. Allen are performing this procedure on select patients at St.Vincent Hospital, Indianapolis, IN.

Patients suitable for this procedure usually fall into one of two categories:

  1. Patients who have a blockage in one or two coronary arteries located on the front side of the heart but are considered too high risk for conventional bypass surgery or balloon angioplasty.
  2. Patients who are otherwise healthy, but have a blockage in one to two coronary arteries located on the front side of the heart.

How Minimally Invasive Direct Coronary Artery Bypass Surgery (MIDCAB) is Performed:

Conventional bypass surgery requires the surgeon to divide the breastbone and stop the patient's heart. A cardiopulmonary bypass (CPB) machine is then used to pump blood through the body while the lengthy surgery is performed.

With MIDCAB, the procedure is performed while the patient's heart is still beating. A three-inch incision is made below the left breast. The blocked coronary artery(s) is bypassed using the internal mammary artery, which runs along the chest wall. Specialized instruments allow the surgeon to attach the artery below the blocked area, restoring a fresh blood supply to the heart.

MIDCAB Benefits are Wide Ranging.

  • The procedure is performed in only two to three hours, compared to the traditional bypass that can take three to six hours. 
  • The recovery time is dramatically reduced from months, to days or weeks.
  • By avoiding the use of the CPB machine, complications are reduced.
  • There is a reduced need for blood transfusions, if any. 
  • Due to less time under anesthesia, patients are moved out of intensive care more quickly. 
  • There is less pain and discomfort. 
  • The incision is cosmetically more acceptable. 
  • There is an estimated saving of up to 40% of the cost of traditional coronary artery bypass surgery.

MIDCAB has shown a 90% effectiveness rate in worldwide studies and has provided substantial relief to approximately 95% of all patients undergoing the procedure.

MIDCAB offers new hope and opportunities for patients who are not eligible for traditional open heart surgery or angioplasty.

© Copyright 2007, CorVasc MD's